Literature DB >> 20113979

Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains.

Ida Parwati1, Reinout van Crevel, Dick van Soolingen.   

Abstract

The wide geographic distribution of one clade of Mycobacterium tuberculosis, the Beijing genotype family, and its genetic homogeneity, suggests that strains belonging to this grouping might have a selective advantage over other M tuberculosis strains. This hypothesis was addressed by reviewing molecular-epidemiological, experimental, and clinical studies. Beijing strains represent about 50% of strains in east Asia and at least 13% of strains worldwide. Their emergence might be linked to escape from BCG vaccination, and to multidrug resistance, which is associated with the Beijing genotype in many areas. Different animal models have shown Beijing strains to be more virulent, and to cause more histopathological changes, higher outgrowth, and increased mortality. At a molecular level, Beijing strains have specific properties in terms of protein and lipid structures and their interaction with the human immune system. Finally, the Beijing genotype has been linked to polymorphisms in immune genes, suggesting the possibility of human-mycobacterial co-evolution. The emergence of the Beijing genotype family might represent an evolutionary response of M tuberculosis to vaccination or antibiotic treatment, with an important negative impact on tuberculosis control. More research is needed to further unravel the mechanisms underlying the emergence of M tuberculosis Beijing genotype strains, and examine the implications for future control strategies. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20113979     DOI: 10.1016/S1473-3099(09)70330-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  167 in total

1.  Clinical and genotypic characteristics of childhood tuberculosis in Chongqing, China.

Authors:  L Xing; R Liu; Q Li; Z Peng; C Zhu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-09       Impact factor: 3.267

2.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

3.  Different patterns of Toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins.

Authors:  M Ioana; B Ferwerda; T S Plantinga; M Stappers; M Oosting; M McCall; A Cimpoeru; F Burada; N Panduru; R Sauerwein; O Doumbo; J W M van der Meer; R van Crevel; L A B Joosten; M G Netea
Journal:  Infect Immun       Date:  2012-02-21       Impact factor: 3.441

4.  Does M. tuberculosis genomic diversity explain disease diversity?

Authors:  Mireilla Coscolla; Sebastien Gagneux
Journal:  Drug Discov Today Dis Mech       Date:  2010

5.  Proposal of a consensus set of hypervariable mycobacterial interspersed repetitive-unit-variable-number tandem-repeat loci for subtyping of Mycobacterium tuberculosis Beijing isolates.

Authors:  Caroline Allix-Béguec; Céline Wahl; Madeleine Hanekom; Vladyslav Nikolayevskyy; Francis Drobniewski; Shinji Maeda; Isolina Campos-Herrero; Igor Mokrousov; Stefan Niemann; Irina Kontsevaya; Nalin Rastogi; Sofia Samper; Li-Hwei Sng; Robin M Warren; Philip Supply
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

6.  BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity.

Authors:  Andrew Keyser; Jolynn M Troudt; Jennifer L Taylor; Angelo A Izzo
Journal:  Vaccine       Date:  2011-10-18       Impact factor: 3.641

7.  Whole genome sequence analysis of multidrug-resistant Mycobacterium tuberculosis Beijing isolates from an outbreak in Thailand.

Authors:  Sanjib Mani Regmi; Angkana Chaiprasert; Supasak Kulawonganunchai; Sissades Tongsima; Olabisi Oluwabukola Coker; Therdsak Prammananan; Wasna Viratyosin; Iyarit Thaipisuttikul
Journal:  Mol Genet Genomics       Date:  2015-04-24       Impact factor: 3.291

8.  Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32.

Authors:  Markus Maeurer; Martin Rao; Alimuddin Zumla
Journal:  Ann Transl Med       Date:  2015-05

9.  Genetic diversity of Mycobacterium tuberculosis Complex in Jos, Nigeria.

Authors:  Agatha Ani; Torbjørn Bruvik; Yetunde Okoh; Patricia Agaba; Oche Agbaji; John Idoko; Ulf R Dahle
Journal:  BMC Infect Dis       Date:  2010-06-26       Impact factor: 3.090

10.  Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival.

Authors:  Susanne Homolka; Stefan Niemann; David G Russell; Kyle H Rohde
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.